EY-Global-Forensic-Data-Analytics-Survey-2014
EY-Global-Forensic-Data-Analytics-Survey-2014
EY-Global-Forensic-Data-Analytics-Survey-2014
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Big risks require big data thinking<br />
<strong>Global</strong> <strong>Forensic</strong> <strong>Data</strong> <strong>Analytics</strong> <strong>Survey</strong> <strong>2014</strong><br />
Figure 18. <strong>Data</strong> volumes by function<br />
26%<br />
Brazil<br />
22%<br />
US<br />
21%<br />
UK<br />
19%<br />
Germany<br />
The top countries with<br />
average data volumes<br />
reported by respondents<br />
exceeding one million records<br />
0 to 10,000<br />
records<br />
10,000 to<br />
100,000<br />
records<br />
100,000 to<br />
1 million<br />
records<br />
1 million to<br />
10 million<br />
records<br />
10 million to<br />
100 million<br />
records<br />
100 million<br />
to a billion<br />
records<br />
Over a<br />
billion<br />
records<br />
Total<br />
Finance<br />
department<br />
excluding<br />
audit<br />
Internal<br />
audit and<br />
risk<br />
Legal/<br />
compliance<br />
Investigations<br />
Business/<br />
management<br />
Other<br />
33% 54% 25% 26% 8% 41% 23%<br />
19% 16% 25% 14% 8% 14% 12%<br />
20% 17% 22% 22% 42% 11% 23%<br />
7% 3% 9% 9% 0% 3% 8%<br />
3% 1% 5% 5% 8% 0% 4%<br />
0% 0% 1% 0% 0% 0% 0%<br />
2% 0% 3% 1% 0% 3% 8%<br />
Q: What data volume do you typically work with in your forensic data analytics tasks?<br />
Base: All respondents (466). The “Don’t know” percentages have been omitted to allow better comparison<br />
among the responses given.<br />
From an industry perspective, only financial services stands out with larger volumes,<br />
as 21% report working with data volumes nearing and over one million records — which<br />
is still relatively small based on what we would expect from such a data-intensive industry.<br />
Effective fraud detection often requires the analysis of hundreds of thousands or millions<br />
of records or communications from multiple systems. It appears that many companies are<br />
failing to adequately leverage FDA to bolster their anti-fraud/anti-corruption efforts,<br />
missing an opportunity, for example, to look for potentially corrupt payments from<br />
complete data sets rather than samples. Given today’s computing power and available<br />
analytic tools, the data volumes under review can often be increased by deploying<br />
sophisticated FDA tools in a cost-effective manner.<br />
22